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The persistence of a latent reservoir containing
transcriptionally silent, but replication-competent,
integratedprovirus is a serious challenge toHIV erad-
ication. HIV integration is under the control of LEDGF/
p75, the cellular cofactor of viral integrase. Investi-
gating possible postintegration roles for LEDGF/
p75, we find that LEDGF/p75 represses HIV expres-
sion in latently infected cells. LEDGF/p75 associated
with two proteins involved in the control of gene
expression and chromatin structure, Spt6 and Iws1,
to form a stable complex. Iws1 plays a role in the
establishment of latent infection, whereas Spt6 func-
tions to recruit Iws1 and LEDGF/p75 to the silenced
provirus and maintains histone occupancy at the
HIV promoter. In latently infected cells, depletion of
the complex results in reactivation of HIV expression
Altogether, our results indicate that a complex con-
taining LEDGF/p75, Iws1, and Spt6 participates in
regulating postintegration steps of HIV latency.
INTRODUCTION
The successful use of antiretroviral therapy (ART) chronically
suppresses HIV replication in infected patients. Yet, in these pa-
tients, the virus can persist in cellular reservoirs, such as latently
infected CD4+ T cells. This reservoir is established early during
the course of infection, can persist for an extended period of
time, and harbors replication competent virus that is the main
source of viral rebound upon ART interruption (Chun et al.,
1997; Finzi et al., 1997). The persistence of the latent reservoir
containing transcriptionally silent integrated HIV is a major bar-
rier to viral eradication. Although this reservoir is mostly consti-
tuted of resting CD4+ T cells, several recent reports indicate
that HIV postintegration silencing occurs frequently in actively
proliferating CD4+ T cells (Dahabieh et al., 2013; Donahue
et al., 2012; Duverger et al., 2009; Jeeninga et al., 2008; van
der Sluis et al., 2013).Cell HostProductive retroviral replication requires the stable integration
of the viral cDNA into a host cell chromosome. HIV integration
occurs preferentially within transcription units (TUs) of transcrip-
tionally active genes, whereasCpG islands and promoter regions
are disfavored (Schro¨der et al., 2002). LEDGF/p75 is a key cellular
cofactor of HIV integrase (Cherepanov et al., 2003; Emiliani et al.,
2005; Turlure et al., 2004) that is responsible for the selective inte-
gration of HIV into active TUs (Ciuffi et al., 2005; Marshall et al.,
2007; Shun et al., 2007). LEDGF/p75 is a chromatin-associated
protein that interacts preferentially with posttranscriptionally
modified histones associated with actively transcribed chro-
matin (Daugaard et al., 2012). The samepreference of HIV to inte-
grate into active genes is also observed in latently infected cells
harboring silenced proviruses. In resting CD4+ T cells from in-
fected individuals on ART, latent HIV proviruses were shown to
be primarily integrated into introns of transcriptionally active
cellular genes (Han et al., 2004). The same pattern was observed
in untreatedpatients (Liu et al., 2006) andconfirmedwith cell lines
(Duverger et al., 2009) or primary CD4+ T cell models of latency
(Shan et al., 2011). These observations suggest that LEDGF/
p75-mediated integration can also lead to silencing.
HIV silencing is the result of combinatorial parameters. At
the level of the integrated promoter, epigenetic mechanisms
involved in the repression of HIV gene expression are taking
place that include the recruitment of DNA- and histone-modi-
fying enzymes as well as chromatin-remodeling complexes
that participate in repressive nucleosome positioning on the
long terminal repeat (LTR) (Van Lint et al., 2013). In addition,
histone chaperones can modulate nucleosome deposition, ex-
change, and removal from chromatin. Among them, Spt6 was
shown to control both basal and Tat-mediated activation of the
HIV promoter (Nakamura et al., 2012; Wu-Baer et al., 1998).
Surprisingly, Spt6 is also required to maintain HIV silencing in
latently infected cells (Gallastegui et al., 2011; Vanti et al., 2009).
Spt6 interacts preferentially with histone H3 (Bortvin and Win-
ston, 1996) and intact nucleosomes (McDonald et al., 2010) and
stimulates transcription elongation rate both in vitro (Endoh et al.,
2004) and in vivo (Ardehali et al., 2009). Spt6 has the ability to re-
assemble nucleosomes in the wake of the elongating RNAPII
(Ivanovska et al., 2011; Kaplan et al., 2003). This activity is impor-
tant to repress cryptic transcription initiation that otherwise oc-
curs within coding regions of transcribed genes (Cheung et al.,& Microbe 17, 107–117, January 14, 2015 ª2015 Elsevier Inc. 107
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Figure 1. LEDGF/p75 Depletion Reactivates HIV Expression
(A) J-Lat A1 cells were transduced with control or LEDGF/p75 shRNAs.
Depletion of LEDGF/p75 expression was monitored by western blotting.
Data are represented as mean ± SD (n = 3), *p<0.05, **p<0.01.
(B) shRNA rescue experiment in J-Lat A1 cells. J-Lat A1 cells were first
transduced with shRNA for 2 days, then transduced with a pLVX vector ex-
pressing either shRNA-sensitive or -resistant form of LEDGF/p75 (HA-p75S
and HA-p75R, respectively). The percentage of GFP+ cells (measuring HIV
reactivation) among mCherry+ cells (expressing HA-p75S or HA-p75R) was
analyzed by flow cytometry 4 (n = 3) or 7 days later (n = 2). Results are shown as
fold induction of HIV expression in shRNA LEDGF/p75-transduced cells (p75)
versus shRNA control cells (Ctrl). Data are represented as mean ± SD. Levels
of inhibition of endogenous LEDGF/p75 and expression of HA-p75S or
HA-p75R were monitored by western blotting.2008; Kaplan et al., 2003). In addition to its role during elonga-
tion, Spt6 also regulates several other stages of transcription.
At promoter regions, Spt6 controls nucleosome positioning dur-
ing transcriptional repression (Adkins and Tyler, 2006; Ivanovska
et al., 2011; Jensen et al., 2008). In fission yeast, Spt6 is involved
in heterochromatin silencing at transcriptional and posttran-
scriptional levels (Kiely et al., 2011).
Spt6 interacts with Iws1/Spn1 in both yeast and mammalian
cells (Krogan et al., 2002; Lindstrom et al., 2003; Yoh et al.,108 Cell Host & Microbe 17, 107–117, January 14, 2015 ª2015 Elsev2007). In yeast, Iws1 associates with coding regions of tran-
scribed genes; however, its profile of occupancy differs from
Spt6 (Mayer et al., 2010). Iws1 is also involved in transcriptional
repression by inhibiting the recruitment of the SWI/SNF chro-
matin-remodeling complex (Zhang et al., 2008). In mammalian
cells, Spt6 recruits Iws1 and Ref/Aly to the elongating RNAPII
complex to control mRNA processing and nuclear export (Yoh
et al., 2007). In addition, the Spt6:Iws1 complex interacts with
elongating RNAPII to promote HYPB/Setd2-mediated H3K36
trimethylation (H3K36me3) (Yoh et al., 2008).
Here, we characterized cellular proteins associated with
LEDGF/p75 and investigated their role in the repression of inte-
grated proviruses and establishment of latency. We report the
identification of a cellular complex that consists of LEDGF/
p75:Iws1:Spt6, where Iws1 is the core of the complex. We
show that Iws1 is involved in the repression of HIV expression
and the establishment of latent infection. Depletion of each of
the three subunits results in the reactivation of latent HIV expres-
sion in CD4+T cell lines and primary lymphocytes. Chromatin
immunoprecipitation (ChIP) assays show that the complex is re-
cruited by Spt6 to the integrated latent provirus and regulates
histone H3 occupancy and trimethyation of H3K27. HIV activa-
tion reduces the binding of LEDGF/p75 and Iws1 to the pro-
moter. Altogether, our results show that in latently infected cells
the LEDGF/p75:Iws1:Spt6 complex contributes to the repres-
sive chromatin state of the HIV promoter, resulting in transcrip-
tional silencing.
RESULTS
LEDGF/p75 Represses HIV Expression in Latently
Infected Cells
To investigate whether LEDGF/p75 is involved in repressing HIV
expression at a postintegration step, LEDGF/p75 was knocked
down in a model cell line for latency harboring a silently inte-
grated HIV minigenome LTR-Tat-IRES-GFP (J-Lat A1) (Jordan
et al., 2001, 2003). The measurement of GFP expression
by flow cytometry is indicative of transcriptional reactivation of
the repressed HIV genome. In this model, HIV expression was
reactivated upon LEDGF/p75 knockdown with three different
shRNA constructs (Figure 1A). Importantly, in LEDGF/p75-
depleted J-Lat A1 cells, expression of shRNA-resistant
LEDGF/p75 (HA-p75R) partially restored HIV silencing, whereas
HIV activation was maintained upon expression of control
small hairpin RNA (shRNA)-sensitive LEDGF/p75 (HA-p75S; Fig-
ure 1B). These results indicate that LEDGF/p75 is involved in the
repression of HIV in a model of latently infected cells.
Iws1 Connects LEDGF/p75 and Spt6
In order to identify whether cellular cofactors of LEDGF/p75
could also participate in HIV repression, we first performed a
yeast two-hybrid screen using the residues 341 to 507 from
the C terminus of LEDGF/p75 as bait. This region contains the in-
tegrase binding domain (IBD) that interacts with HIV-1 integrase
(Emiliani et al., 2005). Using a random primed cDNA library from
the CEM CD4+T lymphocyte cell line, we isolated six indepen-
dent clones corresponding to Iws1, a protein previously identi-
fied as a partner of the histone chaperone Spt6 (Krogan et al.,
2002; Lindstrom et al., 2003) (Figure S1A). To test whether theseier Inc.
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Figure 2. LEDGF/p75, Iws1, and Spt6 form a
Ternary Complex both In Vitro and In Vivo
(A) Purification of LEDGF/p75-associated pro-
teins. Nuclear extracts from SupT1 cells stably
expressing FLAG-HA-epitope-tagged LEDGF/p75
(FH-LEDGF/p75) or expressing an empty vector
(Ctrl) were subjected to sequential immuno-
purification with anti-FLAG- and anti-HA-coated
beads. Proteins were separated by SDS-PAGE
and analyzed by western blotting.
(B) Tandem affinity purification and mass spec-
trometry identification of Iws1 associated proteins
from whole-cell extracts of 293Flp-in cells stably
expressing SBP-CBP-Iws1 (SC-Iws1) or a control
vector (Ctrl).
(C) SC-Iws1 binding proteins were separated by
SDS-PAGE and analyzed by western blotting.
(D) LEDGF/p75 and Spt6 bind separate domains of
Iws1. GST pull-down experiments with nuclear
extracts from 293T cells expressing HA-LEDGF/
p75 with full-length recombinant GST-Iws1 or
deletion mutants. HA-LEDGF/p75 and Spt6 were
detected by western blotting with ant-HA and
anti-Spt6, respectively.
(E) Schematic representation of Iws1 constructs
used in pull-down experiments.
(F) Iws1 binds simultaneously LEDGF/p75 and
Spt6 in vitro. Indicated purified recombinant
proteins were incubated together, coimmunopre-
cipitated with an antibody against LEDGF/p75,
and analyzed by western blotting.
See also Figure S1.proteins could associate in vivo, we performed affinity purifica-
tion of the LEDGF/p75 complex from nuclear extracts of
SupT1 cells stably transduced with LEDGF/p75 fused to FLAG
and HA epitope tags (FH-LEDGF/p75). Western blot analysis de-
tected the association of both endogenous Iws1 and Spt6 with
FH-LEDGF/p75 (Figure 2A). To confirm the interaction of these
three proteins, we purified the Iws1-associated complex from
whole-cell extracts of stable 293 cell line expressing Iws1 fused
to tandem affinity tags, a streptavidin binding peptide (SBP),
and a calmodulin binding peptide (CBP; SC-Iws1). Mass spec-
trometry analysis identified both LEDGF/p75 and Spt6 as
binding partners for SC-Iws1 (Figure 2B). These interactions
were confirmed by western blot analysis of streptavidin-purified
Iws1 with specific antibodies (Figure 2C).
To gain insights into the molecular organization of the LEDGF/
p75:Iws1:Spt6 complex, we mapped the interacting domains.
We performed GST-pull down analysis with truncated forms of
recombinant GST-Iws1 and nuclear extracts of 293T cells ex-
pressing HA-tagged LEDGF/p75. HA-LEDGF/p75 bound theCell Host & Microbe 17, 107–117full length as well as the C-terminal region
(amino acids 300–819) of Iws1 but failed
to interact with its N-terminal domain
(amino acids 1–300) (Figure 2D lanes 2
to 4). By further deleting the N-terminal
extremity of Iws1, we identify the region
containing amino acid residues 451 to
500 of Iws1 to be required for interaction
with LEDGF/p75 (Figure 2D, lanes 5to 8). Similar results were obtained using recombinant His6-
LEDGF/p75 (Figure S1B available online). The same purified
truncated forms of GST-Iws1 were used to determine the Spt6
binding domain.We identified the C-terminal region (amino acids
555–819) of Iws1 to be required for Spt6 interaction (Figure 2D).
Both the WT C-terminal domain of Iws1 (amino acids 300–819)
and a mutant lacking the LEDGF/p75 binding domain (GST-
Iws1301-819 D451-500) interacted equivalently with recombinant
HIS6-FLAG-Spt6 (Figure S1C), confirming that LEDGF/p75 and
Spt6 interact with two distinct regions of Iws1 (Figure 2E).
The ability of Iws1 to directly connect LEDGF/p75 and Spt6
was further explored by in vitro coimmunoprecipitation experi-
ments with recombinant purified proteins LEDGF/p75, His6-
FLAG-Spt6, and GST-Iws1301-819 (Figure 2F, lanes 1 to 3, and
S1D). Recombinant proteins were incubated and immunoprecip-
itated using an antibody directed against LEDGF/p75. A weak
but reproducible interaction was detected between His6-FLAG-
Spt6 and LEDGF/p75, whereas GST-Iws1301-819 strongly bound
LEDGF/p75 (Figure 2F, lanes 7 and 8). In the presence of, January 14, 2015 ª2015 Elsevier Inc. 109
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Figure 3. Iws1 Represses HIV Expression at
a Postintegration Step and Participates in
the Establishment of Latency
(A) HeLa cells were transfected with control (Ctrl),
Luciferase (Luc), or Iws1 siRNA. Iws1 depletion
was monitored 48 hr later by western blotting.
(B) siRNA-treated HeLa cells from (A) were in-
fected with a VSVg-pseudotyped NL4-3 Denv-Luc
virus. Viral expression wasmonitored 48 hr later by
measuring luciferase activity. Shown are means ±
SD (n = 3). *p < 0.05.
(C) Real-time PCR quantification of integrated viral
DNA at 48 hr postinfection in siRNA-treated cell
from (B). Data are represented asmean± SD (n = 3).
(D) Western blotting analysis of SupT1 cell extracts
6 days after transduction of control or Iws1 shRNA.
(E) Depletion of Iws1 does not affect the percentage
of HIV productive infections in SupT1 cells. GFP+
cells indicative of productive infection were
measured 4 hours postinfection by flow cytometry
(left). Iws1 depletion increases LTR activity, as
monitored by measuring GFP. MFI by flow cy-
tometry is shown on the right. Data are represented
as mean ± SD (n = 4). **p < 0.01.
(F) Iws1 is required for HIV latency establishment
in SupT1 cells. GFP cells were sorted 4 days
postinfection with the HIV vector LTR-Tat-IRES-
GFP, and latent infections were quantified after
reactivation with TNF-a (10 ng/ml). Data are repre-
sented as mean ± SD (n = 4). *p < 0.05.
See also Figures S2 and S3.GST-Iws1301-819, Spt6 robustly coimmunoprecipitated with
LEDGF/p75 (Figure 2F, lane 9). On the contrary, addition of
GST-Iws1 lacking the LEDGF/p75 binding domain (GST-
Iws1301-819 D451-500) failed to stimulate the interaction of LEDGF/
p75 with Spt6 (Figure 2F, lanes 10 and 11) while retaining its
ability to associate with Spt6 (Figure S1C). Altogether, our results
indicate that, by directly interacting with two distinct domains
of Iws1, Spt6 and LEDGF/p75 coexist in the same complex.
Loss of Iws1 Stimulates HIV Expression at a
Postintegration Step
The identification of Iws1 as a binding partner of LEDGF/p75
prompted us to assess the role of this protein in HIV replication.
HeLa cells were treated with a small interfering RNA (siRNA)
directed against Iws1 or control siRNAs (Figure 3A). Then, cells
were infected with VSVg-pseudotyped HIV-Denv-Luc, and viral
expression was monitored by measuring luciferase activity. Sur-
prisingly, knockdown of Iws1 significantly increased HIV expres-
sion by more than 3-fold, whereas a siRNA-targeting luciferase
mRNA almost abrogated the detection of luciferase activity (Fig-
ure 3B). Given that Iws1 interacts with LEDGF/p75, the impact of
Iws1 depletion on HIV expression could simply reflect an effect
on integration. To address this possibility, we quantified proviral
integration by quantitative PCR in these cells. Interestingly, Iws1
depletion did not affect HIV integration, indicating that Iws1 con-
trols viral gene expression of integrated proviruses at a postinte-
gration step (Figure 3C).
Iws1 Participates in the Establishment of HIV Latency
The enhanced HIV expression observed upon depletion of Iws1
suggests that Iws1 acts as a transcriptional repressor and could110 Cell Host & Microbe 17, 107–117, January 14, 2015 ª2015 Elsevpotentially contribute to the silencing of HIV. Thus, we explored
the contribution of Iws1 to the establishment of latency by
measuring the percentage of productively versus latently in-
fected cells in the presence or absence of Iws1 using a method
previously described (Rafati et al., 2011). At day 6 after shRNA
transduction, SupT1 cells were infected with a virus containing
the HIV minigenome LTR-Tat-IRES-GFP. Both the GFP-positive
and the -negative cell population that contain noninfected cells
as well as cells harboring latent proviruses were sorted by flow
cytometry 4 days postinfection. GFP-negative cells were treated
with TNF-a 24 hr later in order to reactivate silent proviruses, and
the percentage of latently infected cells was quantified by flow
cytometry. Iws1 knockdown had no effect on the percentage
of productively infected cells (Figures 3D and 3E). However, the
mean of GFP fluorescence intensity (MFI) indicating HIV LTR ac-
tivity was increased by 2-fold in Iws1-depleted cells (Figure 3E).
These data confirmed results from Figure 3B and showed that
Iws1 represses viral transcription at a postintegration stage.
Interestingly, depletion of Iws1 significantly reduced the percent-
age of latently infected cells from 5.3% in control cells to 2.8% in
Iws1-depleted cells (Figure 3F). Unexpectedly, depletion of Spt6
in the same experiment strongly impaired HIV reverse transcrip-
tion, precluding the study of its role at later stages of viral replica-
tion (Figure S2). To accurately quantify latently infected cells, we
constructedanHIVdual-color vector, namedHIVGmC,basedon
the HIV minigenome LTR-Tat-IRES-GFP (Jordan et al., 2001,
2003),in which a CMV-mCherry cassette was introduced after
the GFP coding region (Figure S3A). To confirm the role of Iws1
in the establishment of HIV latency, SupT1 cells were first trans-
duced with control or Iws1 shRNA and infected 6 days later with
increasing amounts of HIV GmC. A double-positive populationier Inc.
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Figure 4. LEDGF/p75, Iws1, and Spt6 Partic-
ipate in the Maintenance of HIV Latency in
J-Lat Cells
(A) J-Lat A1 cells were transduced with control
(Ctrl), LEDGF/p75, Iws1, or Spt6 shRNA. GFP
expression was monitored by flow cytometry at
days 6 and 9 posttransduction. Data are repre-
sented as mean ± SD. At day 6, for LEDGF/p75
and Iws1, **p < 0.01 (n = 7) and for Spt6: *p < 0.05
(n = 4) and at day 9 for LEDGF/p75 and Iws1, **p <
0.01 (n = 6) and ***p < 0.001 (n = 6).
(B) J-Lat A2 cells were transduced as described in
(A). Data are represented as mean ± SD. At day 6,
for LEDGF/p75 and Iws1, **p < 0.01 (n = 6), and for
Spt6, *p < 0.05 (n = 6), and at day 9 for LEDGF/p75
and Iws1, **p < 0.01 (n = 6).
(C) J-Lat 10.6 cells were transduced with indicated
shRNA, as in (A) and (B). Data are represented as
mean+/SD. At day 6, for LEDGF/p75 and Iws1,
*p < 0.05 (n = 5), and at day 9 for LEDGF/p75 *p <
0.05 (n = 4) and Iws1, **p < 0.01 (n = 4) and for Spt6:
*p < 0.05 (n = 3).
(D) Depletion of LEDGF/p75, Iws1 and Spt6 in-
crease levels of HIV mRNA. Real-time quantifica-
tion of HIV mRNA levels in J-Lat A1 cells, 6 days
after transduction with the indicated shRNA vec-
tors. Data are represented as mean ± SD (n = 3).
*p < 0.05, **p < 0.01.
(E and F) Immunoblot analysis of protein expres-
sion in J-Lat A1 and A2 (E) and 10.6 (F) at day 6
posttransduction of the indicated shRNA.
See also Figures S4 and S5.(GFP+/mCherry+) corresponding to productively infected cells
wasdetected 48 hr postinfection (Figure S3B).OurHIVGmCvec-
tor also allowed the detection of a single-positive population
(GFP/mCherry+) corresponding to latently infected cells (Fig-
ure S3B). Upon Iws1 depletion, we observed a significant activa-
tion of HIV promoter expression, whereas the percentage of
latently infected cells diminished at the highest viral dose (Figures
S3C and S3D). These results show that Iws1 is involved in the
repression of newly integrated proviruses and contributes to
the establishment of HIV latency.
The LEDGF/p75:Iws1:Spt6 Complex Is Required to
Maintain HIV Silencing in Latently Infected Cells
To address the role of the LEDGF/p75:Iws1:Spt6 complex in the
control of HIV silencing, we depleted the different subunits ofCell Host & Microbe 17, 107–117the complex with shRNA in three clonal
Jurkat cell lines (J-Lat A1 and A2, con-
taining HIV minigenome, and J-Lat 10.6,
containing a full-length HIV genome-
expressing GFP in place of Nef). For
each of the three J-Lat cell lines that
we analyzed, depletion of LEDGF/p75,
Iws1, or Spt6 resulted in a 2- to 10-fold
reactivation of the latent provirus, as
monitored by an increase in the percent-
age of GFP-positive cells (Figures
4A4C). In J-Lat A1 cells, the most
robust reactivation was observed uponIws1 depletion, leading to a 10-fold increase in percent of
GFP+ cells at day 9 (Figure 4A). Transduction of the Spt6 shRNA
for 6 days started to induce apoptosis in J-Lat A1 and A2 cells,
preventing the study of its effect at later time point (Figure S4). In
J-Lat A1 cells, we observed an accumulation of viral mRNA
upon LEDGF/p75, Iws1, or Spt6 depletions that mirrored the in-
crease in percentage of GFP+ cells (Figure 4D). The efficiency of
the shRNA knockdowns in J-Lat A1, J-Lat A2, and J-Lat 10.6
cell lines was monitored by western blot analysis at day 6 after
transduction (Figures 4E and 4F). Importantly, in J-Lat 10.6
cells, complementation experiments showed that re-expression
of either shRNA-resistant LEDGF/p75 (HA-p75R) or Iws1 (T7-
Iws1R) counteracts HIV reactivation mediated by the depletion
of LEDGF/p75 or Iws1, respectively (Figure S5). Altogether,
these results demonstrate that LEDGF/p75, Iws1, and Spt6, January 14, 2015 ª2015 Elsevier Inc. 111
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Figure 5. Depletion of LEDGF/p75, Iws1, and
Spt6 Increases HIV Expression in Infected
CD4+T Lymphocytes
(A) Schematic representation of the RGH virus
used in this study. FACS analysis of SupT1 cells
infected with RGH. Cells were transduced with
indicated shRNA 48 hr postinfection and selected
with puromycin for 6 days. Dot plot analysis
showing populations of productively (GFP+/
mCherry+) and latently (GFP/mCherry+) infected
SupT1 cells after treatment with indicated shRNA.
(B) Western blotting analysis of shRNA-mediated
depletion of LEDGF/p75, Iws1, and Spt6 in SupT1
cells.
(C and D) Quantification of productive (C) and
latent (D) infections after shRNA-mediated deple-
tion in SupT1 cells. Data are represented as
mean ± SD (n = 3). *p < 0.05, **p < 0.01.
(E) FACS analysis of activated primary CD4+T cells
from a healthy donor infected with RGH. Cells were
transduced with indicated shRNA 48 hr post-
infection and selected with puromycin for 6 days.
(F) Western blotting analysis of shRNA-mediated
depletion of LEDGF/p75, Iws1, and Spt6 in acti-
vated primary CD4+T cells.
(G and H) Quantification of productive (G) and
latent (H) infections after shRNA-mediated deple-
tion in activated primary CD4+T cells from four
healthy donors. Data are represented as mean ±
SD (n = 4). *p < 0.05.contribute to the maintenance of HIV silencing in latently in-
fected cells.
To further assess the role of LEDGF/p75, Iws1, and Spt6 on
the maintenance of HIV latency, we used the red-green HIV-1
(RGH) virus containing an LTR-driven Gag-eGFP and a CMV-
driven mCherry fluorescent protein in place of nef (Dahabieh
et al., 2013). SupT1 cells were first infected with the HIV RGH vi-
rus. Cells were transduced with shRNA 48 hr postinfection, and
HIV infection was measured after 6 days by flow cytometry.
Infection of SupT1 cells with RGH resulted the detection of
both productive (GFP+/mCherry+) and latent (GFP/mCherry+)
cells (Figure 5A). Depletion of LEDGF/p75, Iws1, and Spt6 led to
an increase of the LTR-driven GFP expression (by 1.3-, 2.0-, and112 Cell Host & Microbe 17, 107–117, January 14, 2015 ª2015 Elsevier Inc.1.9-fold, respectively; Figures 5B and 5C).
In addition, we observed a limited but sig-
nificant decrease of latently infected cells
upon LEDGF/p75 depletion (Figure 5D).
Given that recent studies have reported
that infection of activated primary CD4+ T
lymphocytes also yielded a population of
latently infected cells (Calvanese et al.,
2013; Dahabieh et al., 2013), we investi-
gated the role LEDGF/p75, Iws1, and
Spt6 in such a model. Primary CD4+ T
lymphocytes were purified, activated
with anti-CD3- and anti-CD28-coated
beads for 72 hr and then infected with
RGH. Cells were transduced with indi-
cated shRNA 48 hr postinfection, and
HIV infection was measured after 6 daysby flow cytometry. We observed two small populations corre-
sponding to productively and latently infected cells (Figure 5E).
Depletion of LEDGF/p75 and Iws1 resulted in a significant
increase of the percentage of productively infected cells (Figures
5F and 5G). In addition, an increase in the percentage of latently
infected cells was observed upon depletion of each of
the three cofactors (Figure 5H). These results suggest that
the double-negative cell population (GFP/mCherry) also
contains silenced integrated proviruses that can be partially
(GFP/mCherry+) or totally (GFP+/mCherry+) derepressed
upon depletion of LEDGF/p75, Iws1, and Spt6. Taken together,
our data indicate that LEDGF/p75, Iws1, and Spt6 participate
in the maintenance of HIV silencing.
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Figure 6. Spt6 Recruits Iws1 and LEGDF/
p75 to the Latent HIV Genome and Partici-
pates inMaintenance of Repressive Nucleo-
somal Architecture of the LTR
(A) ChIP analysis of LEDGF/p75, Iws1, and Spt6
occupancy at the LTR and GAPDH TSS in J-Lat A1
cells. Data are represented as mean ± SD (n = 3).
(B) Immunoblot analysis of protein expression
in J-Lat A1 at day 6 after transduction of the
indicated shRNA vectors.
(C) LEDGF/p75 ChIP analysis of the LTR and
coding regions of HIV in A1 J-Lat cells transduced
with the indicated shRNA. Results are shown as
percentage of input. Data are represented as
mean ± SD (n = 3 for LTR and n = 4 for coding
region). *p < 0.05, **p < 0.01.
(D) Same as (B) except an anti-Iws1 antibody was
used (n = 3). *p < 0.05, **p < 0.01.
(E) Same as (B) except an anti-Spt6 antibody was
used (n = 3 for LTR and n = 4 for coding region).
*p < 0.05, **p < 0.01.
(F) ChIP analysis of histone H3 in J-Lat A1 cells
transduced with LEDGF/p75, Iws1 and Spt6
shRNA shRNA (left panel, n = 4; middle panel,
n = 3). *p < 0.05.
(G) Same as (E) except an anti-H3K27me3
antibody was used (n = 3). *p < 0.05, **p < 0.01.
(H) ChIP analysis of LEDGF/p75, Iws1, Spt6, and
histone H3 occupancy at the LTR region in J-Lat
A1 treated with TSA or mock-treated for 18 hr.
Percentage of input in mock-treated cells was set
to one. Results shown are the mean ± SD (n = 3).
*p < 0.05, **p < 0.01.
See also Figure S6.Spt6 Recruits Iws1 and LEDGF/p75 and Maintains a
Repressive Chromatin Structure at the HIV LTR
Next, we asked whether the LEDGF/p75:Iws1:Spt6 complex is
positioned in cis on the latent proviruses in order to participate
in the maintenance of a repressive state. We performed quanti-
tative ChIP experiments in order to assess the occupancy of
LEDGF/p75, Iws1, and Spt6 at integrated HIV genomes. Under
basal conditions, each of the complex subunits was found to
associate with the LTR, transcription start site (TSS), and coding
region of the HIV genome in both J-Lat A1 and J-Lat 10.6 cell
lines (Figure S6). Compared to the active GAPDH promoter,
the complex subunits were enriched at the silenced LTR (Fig-Cell Host & Microbe 17, 107–117ure 6A). To further characterize the orga-
nization of the LEDGF/p75:Iws1:Spt6
complex on latent HIV proviruses, we per-
formed ChIP experiments upon shRNA-
mediated depletion of each of the three
subunits. Because the shRNA lentivector
shares the same LTR U5 sequence as the
integrated HIV minigenome in J-Lat cells,
we restricted our ChIP analysis to the LTR
U3 region and the coding sequence.
shRNA-mediated knockdown of LEDGF/
p75, Iws1, and Spt6 in J-Lat1 cells was
confirmed bywestern blotting (Figure 6B).
Depletion of Iws1 and Spt6 effectivelyreduced the level of LEDGF/p75 both at the LTR and within
the coding region (Figure 6C). In contrast, Iws1 occupancy was
only significantly affected by depletion of Spt6 and remained un-
changed in LEDGF/p75 knockdown cells (Figure 6D). Moreover,
neither Iws1 nor LEDGF/p75 depletion had a significant effect on
Spt6 recruitment at the HIV genome (Figure 6E). Spt6 is a histone
chaperone that has the ability to maintain a repressive chromatin
structure at promoters (Adkins and Tyler, 2006; Ivanovska et al.,
2011; Jensen et al., 2008). Given that silencing of the HIV-1
LTR requires the positioning of repressive nucleosomes (Jordan
et al., 2001, 2003; Rafati et al., 2011; Verdin et al., 1993), we
analyzed nucleosome occupancy as indicated by histone H3, January 14, 2015 ª2015 Elsevier Inc. 113
presence upon shRNA-mediated depletion of LEDGF/p75, Iws1,
and Spt6. Knockdown of Spt6 reduced H3 levels both at the
HIV promoter and coding region (Figure 6F). Depletion of Iws1
and LEDGF/p75 also significantly diminished H3 occupancy at
the LTR, albeit to a lesser extent (Figure 6F). Concomitant to
the reactivation of HIV expression, the level of the repressive
chromatin mark H3K27me3 at the coding region sharply
decreased in cells depleted for the complex subunits. In addi-
tion, Spt6 was also required to maintain H3K27me3 at the
promoter (Figure 6G).
Taken together, our results indicate that Spt6 participates in
the positioning of Iws1 and LEDGF/p75 at the latent HIV genome
and confirm our in vitro and in vivo data showing that Iws1 is
the core of the complex and connects Spt6 to LEDGF/p75.
This complex participates in themaintenance of repressive chro-
matin architecture at the HIV promoter region that restricts
transcription.
Recruitment of LEDGF/p75 and Iws1 to the Latent HIV
Provirus Is Reduced upon Transcriptional Reactivation
To determine whether HIV reactivation alters the occupancy of
the complex at the HIV promoter, J-Lat A1 cells were treated
with the histone deacetylase (HDAC) inhibitor trichostatine A
(TSA) in order to reactivate HIV expression. There was a 50%
decrease of histone H3 bound to the LTR region upon TSA treat-
ment (Figure 6H). Remarkably, TSA also reduces LEDGF/p75
and Iws1 occupancy by 1.6- and 3-fold, respectively, whereas
Spt6 remained associated to the viral promoter (Figure 6H).
Thus, the LEDGF/p75:Iws1:Spt6 complex is directly recruited
to the integrated provirus under repressive conditions, and
HDAC-inhibitor-mediated reactivation of HIV correlates with
the dissociation of LEDGF/p75 and Iws1 from the LTR.
DISCUSSION
In this study, we identified a nuclear complex LEDGF/
p75:Iws1:Spt6 that binds repressed HIV genomes. This complex
contributes to maintenance of HIV latency by controlling histone
occupancy on the LTR and inhibiting viral expression. In addi-
tion, we showed that Iws1 is also involved in the establishment
of postintegration silencing of HIV. It is tempting to speculate
that this complex could be a cornerstone for the coordination
of HIV integration and transcriptional control, ultimately leading
to latency. Indeed, LEDGF/p75 is a key cofactor of HIV integrase
that targets integration in active transcription units contributing
to subsequent proviral gene expression. However, a growing
amount of evidence has highlighted that rapid silencing of inte-
grated proviruses occurs frequently during HIV infection of
actively proliferating CD4+ T cells (Dahabieh et al., 2013; Dona-
hue et al., 2012; Duverger et al., 2009; Jeeninga et al., 2008; van
der Sluis et al., 2013). Here, we showed that LEDGF/p75, Iws1,
and Spt6 contribute to nonproductive infections in proliferating
lymphocytes. By returning to a resting state, these latent infected
cells could contribute to the viral reservoir. These results indicate
that, in certain conditions, integration and transcriptional repres-
sion can be tightly coordinated. A key finding from this study is
that, aside from its key role in integration, LEDGF/p75, along
with Iws1 and Spt6, also contributes to postintegration HIV
silencing.114 Cell Host & Microbe 17, 107–117, January 14, 2015 ª2015 ElsevLEDGF/p75 is a cellular chromatin-associated protein thatwas
first identifiedasa transcriptional activator (GeandRoeder, 1994;
Ge et al., 1998; Yokoyama and Cleary, 2008). Subsequently,
several partners of LEDGF/p75 were identified, among them
JPO2, a Myc-interacting protein that represses transcription
(Bartholomeeusen et al., 2007;Maertens et al., 2006), andMenin,
a molecular adaptor interacting with MLL1 (Yokoyama and
Cleary, 2008). In addition, LEDGF/p75 cooperates with C-termi-
nal binding protein-interacting protein and promotes DNA repair
by homologous recombination (Daugaard et al., 2012). The func-
tional diversity of these cofactors suggests that LEDGF/p75 is
likely to be involved in a broad range of cellular mechanisms at
the crossroad of DNA repair and transcriptional control of gene
expression. Using combinatorial approaches, we found that
Iws1 physically connects LEDGF/p75 and Spt6 by two separate
domains, allowing the three subunits to be part of the same
biochemical entity. In addition, we did not find any of the
LEDGF/p75 partners previously identified to copurify with Iws1,
suggesting that LEDGF/p75binds Iws1within adistinct complex.
Inhibition of HIV transcription correlates with the establish-
ment of a repressive chromatin organization at the LTR. In partic-
ular, a nucleosome nuc1 positioned downstream of the TSS in
repressive conditions is specifically disrupted upon transcription
activation (Verdin et al., 1993). Different classes of chromatin-
associated complexes contribute to the LTR nucleosome posi-
tioning, including histone-modifying enzymes and the Brg1/
Brm associated factor (BAF) chromatin remodeling complex
(Rafati et al., 2011; Van Lint et al., 2013). The effect of the histone
chaperone Spt6 in maintaining histone H3 occupancy at the
silenced LTR could mirror the role previously described for
Spt6 in regulating transcription initiation by controlling nucleo-
some positioning at promoters (Adkins and Tyler, 2006; Ivanov-
ska et al., 2011; Jensen et al., 2008). In the case of the yeast
CHA1 gene, depletion of Spt6 results in the displacement of
the +1 nucleosome that otherwise occludes the TATA box and
TSS, indicating that Spt6 positions nucleosomes under repres-
sive conditions (Ivanovska et al., 2011). Our data suggest that
Spt6 plays a similar role by maintaining a repressive nucleosome
organization at the silenced HIV promoter along with the posi-
tioning of LEDGF/p75 and Iws1. This finding is consistent with
previous studies showing that Spt6 silences HIV expression
(Gallastegui et al., 2011) and controls histone occupancy of a
stably integrated HIV promoter (Nakamura et al., 2012). In addi-
tion, our ChIP experiments revealed that Spt6 controls the occu-
pancy of Iws1 and LEDGF/p75 along the integrated provirus.
However, we cannot rule out that the loss of LEDGF/p75 upon
Spt6 depletion could be the indirect result of the loss of histone
H3. Indeed, LEDGF/p75 possesses a chromatin binding PWWP
domain that could also participate in the recruitment of the
complex. Nevertheless, our ChIP experiments clearly indicate
that LEDGF/p75 is not sufficient to recruit Iws1 and Spt6 to the
HIV genome. Interestingly, reactivation of HIV expression upon
HDAC inhibitor treatment resulted in a significant decrease of
LEDGF/p75 and Iws1 from the promoter, whereas Spt6 occu-
pancy was not altered. These results suggest that, in addition
to its role in maintaining a repressive state of the LTR, Spt6 is
likely to be involved in transcription activation steps of HIV.
The interaction between Iws1 and Spt6 regulates several
aspect of gene expression. Interestingly, Iws1 was shown toier Inc.
repress transcription of the yeast CYC1 gene by preventing the
recruitment of the chromatin remodeler SWI/SNF complex to
the promoter region, an inhibition that is abrogated by Spt6
(Zhang et al., 2008). We and others have reported that SWI/
SNF remodeling complexes are actively recruited to the HIV
promoter by directly interacting with the viral transactivator Tat
(Agbottah et al., 2006; Mahmoudi et al., 2006; Tre´and et al.,
2006). Thus, one possible mechanism is that Iws1 could inhibit
the recruitment of chromatin remodelers therefore preventing
chromatin relaxation that is critical for transcriptional activation.
However, unlike its yeast counterpart we show that Spt6 does
not depend upon Iws1 to bind chromatin, a result consistent
with previous findings (Yoh et al., 2007, 2008). In addition, our
data clearly indicate that depletion of Iws1 strongly reactivates
HIV expression, though it has limited effects on histone occu-
pancy at the LTR. This result suggests that Iws1 must possess
additional functions to repress viral transcription.
Finally, our data suggest that Iws1 is not directly implicated in
the integration step. In addition, we also found that residues in
the IBD of LEDGF/p75 that are important for IN interaction are
also required for Iws1 binding (A.G., E.S., and S.E., unpublished
data). Therefore, it seems unlikely that IN and Iws1 could bind
simultaneously to the same LEDGF/p75 protein. One hypothesis
is that incoming HIV integrase within the preintegration complex
could displace Iws1 to bind LEDGF/p75.
The role of LEDGF/p75 in the selective targeting of HIV inte-
gration into active transcriptional units and the recognition of
active chromatin modifications are both well described. Our
study describes a postintegration role for LEDGF/p75 in recruit-
ing cofactors that are repressive for viral transcription, resulting
in the establishment and maintenance of latency. These seem-
ingly opposing roles highlight the multifunctional nature of
LEDGF/p75, capable of both reading active chromatin modifi-
cations (e.g., H3K36me3) to selectively target integration
into active TUs and also interacting with cofactors such as
Iws1 and Spt6, which could induce repressive chromatin struc-
ture. Future experiments will indicate whether the LEDGF/
p75:Iws1:Spt6 complex is strictly involved in postintegration
transcriptional control or is also playing a role in HIV integration
site selection.EXPERIMENTAL PROCEDURES
Cell Lines
Jurkat clones J-Lat A1, A2, and 10.6 have been previously described (Jordan
et al., 2003). HEK293T cells were grown in DMEM plus glutamine, antibiotics,
and 10% decomplemented fetal calf serum (FCS; Life Technologies). SupT1
and J-Lat cells were grown in RPMI 1640 plus glutamine, antibiotics, and
10% decomplemented FCS (Life Technologies). 293Flp-in cells (Life Technol-
ogies) stably expressing SBP-CBP-Iws1 (SC-Iws1) were obtained by
cotransfection of the pcDNA5-FRT plasmid encoding SC-Iws1 and the Flp
recombinase expression plasmid (pOGG44; Life Technologies). SupT1 stably
expressing FLAG-HA-LEDGF/p75 were obtained by stable transduction of a
pOZ retroviral vector expressing full-length LEDGF/p75 fused to HA and
FLAG epitopes. GST fusion vectors expressing full-length or truncated Iws1
proteins were constructed by PCR amplification from a cDNA clone (MGC-
8804; ATCC) and insertion into the pGEX-6P1 plasmid (GE Healthcare).
Purification and Infection of Primary CD4+T Lymphocytes
Peripheral blood mononuclear cells were obtained from unidentified healthy
donors within a convention between INSERM and Etablissement Franc¸aisCell Hostdu Sang. CD4+ T cells were isolated by negative sorting with the human naive
T cell isolation kit (Miltenyi Biotec) and activated with the T cells activation
and expansion kit (Miltenyi). Three days after activation, Dynabeads were
removed with an LS column and a MACS manual separator (Miltenyi).
Activated T cells were reseeded at 1 3 106 cells/ml in complete medium
with 30 IU/ml of rIL-2 for 3 days at 37C. Then, 2 3 106 activated CD4+T cells
were spinoculated at 800 3 g for 2 hr at 37C with 250 ng of CAp24 of RGH
vector particles in 300 ml of complete medium. After spinoculation, cells were
washed twice in PBS and reseeded at 1 3 106 cells/ml in complete medium
with 30 IU/ml of rIL-2. Cells were transduced with indicated shRNA lentivector
particles 48 hr postinfection and selected for 6 days with mg/ml puromycin
(Sigma-Aldrich).
Flow Cytometry Analysis
Cell fluorescence of J-Lat cells wasmeasured with a FACSCalibur flow cytom-
eter and analyzed with the Cell Quest software (BD Biosciences). shRNA
complementation assay was analyzed on a Fortessa LSR flow cytometer
(BD Biosciences). Cell sorting was performed on FACSAria III cell sorter (BD
Biosciences) and analyzed with BD FACSDiva.
Analysis of HIV Expression by Real-Time PCR
Total RNA was extracted with an RNeasy mini kit (Qiagen). cDNA was
synthesized with a High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems) and quantified by real-time PCR with a LightCycler 480 SYBR
Green I Master (Roche) and the RT8 and RT9 primers (Gallastegui et al.,
2011). Viral cDNA were normalized to GAPDH transcripts.
Chromatin Immunoprecipitation
ChIP in J-Lat cells was performed with the HighCell# ChIP kit (Diagenode)
according to the manufacturer’s instruction. Sonication was performed with
a Bioruptor UCD-200 for 45 min at 4C with 30 s on/30 s off cycles. ChIP
samples were analyzed with real-time PCR using a LightCycler LC480
(Roche). ChIP values were normalized as a percentage of input. The following
antibodies were used for ChIP: anti-Spt6 (Ab32820, Abcam), anti-Iws1
(16943-AP, Proteintech), anti-LEDGF/p75 (611715, BD Biosciences), anti-
histone H3 (CS-135-100, Diagenode), and anti H3K27me3 (07-449, Millipore).
Oligonucleotides and probes used to amplify the HIV promoter, TSS,
and GFP coding region are described in the Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.chom.2014.12.002.
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